✕
For Patients & Families
Our Science
Connect with Us
At Astria, our steadfast commitment to the communities we serve is at the heart of our patients-first, people always mission. The lived experiences of people impacted by allergic and immunologic diseases is woven into our core values and everything we do. This commitment and approach mean that the needs and preferences of patients and their loved ones shape our decisions at every phase of drug development.
Earnest, collaborative and compliant patient advocacy and engagement are essential to our collective success. We believe that by working with people who have hard-won expertise with the diseases we aim to treat, we can advance science, enhance treatments, and ensure access more effectively together than we ever could alone.
Areas of Focus
Engage – We seek and actively listen to the needs, preferences, and experiences of people living with allergic and immunologic conditions and integrate these insights into our work, at every stage of drug development.
Invest – We support the vital work of patient communities through investments of our time, expertise, and appropriate financial support to advance community-driven priorities, with an enhanced commitment to amplifying disease awareness and community outreach.
Empower – We provide education highlighting the challenges and burden of disease and its treatment to encourage meaningful patient-physician connections and shared-decision making. Our efforts focus broadly on the impact of disease, including the burden on one’s mental health, caregivers and families.
Envision – We see a future where the experience of living with allergic and immunologic diseases has been transformed by improvements in care, treatment, education, and access to medicines. We are committed to being a part of innovative solutions that will empower patients to break free from the gravity of their disease.
Regan Sherman
Regan has nearly 20 years’ experience working with patient communities, both as an advocate and as a facilitator between life science companies and the people they aspire to help. She has worked extensively with organizations and advocates representing people living with cancer, rare and ultra-rare genetic conditions and neuromuscular disease.
Regan leads a team of advocacy professionals dedicated to ensuring that Astria’s work is informed by the lived experience of patients and that our genuine commitment to make a positive difference is realized through our community engagement. She believes that hope is a verb and that outcomes are improved when we achieve them together.
Kelly Fitzsimmons
Kelly has been advocating for patients and families for 20+ years, working in maternal-fetal, neonatal, immunology, genetic disorders and rare diseases. Kelly is dedicated to building meaningful connections and amplifying the voices of those living with life-altering conditions and diseases. She takes pride in working with and supporting patient organizations on educational and other patient-focused initiatives and integrating both empathy and patient-expert insights into the full spectrum of Astria’s clinical programs.
Liz Rowe
Liz transitioned from a clinical healthcare background to rare disease patient engagement and advocacy three years ago, when she became a rare caregiver. Liz has worked in a variety of rare conditions including allergy/immunology, hematology, neurology, and genetic and metabolic disorders. She is honored to forward Astria’s commitment to “Patients First, People Always” by connecting patient and caregiver experiences with clinical development.
